Results 131 to 140 of about 232,520 (220)

A Pharmacometrics-Informed Trial Simulation Framework for Optimizing Study Designs for Disease-Modifying Treatments in Rare Neurological Disorders. [PDF]

CPT Pharmacometrics Syst Pharmacol
Ryeznik Y, Hilgers RD, Heussen N, Comets E, Mentré F, Hendrickx N, Karlsson MO, Hooker AC, Hamdan A, Chen X, Schüle R, Synofzik M, Sverdlov O.   +12 more
europepmc   +1 more source

Neuropilin-1 expression modulates infection susceptibility to murine cytomegalovirus at the materno-fetal interface. [PDF]

J Virol
Fonseca Brito L, Ostermann E, Kottlau J, Tödter S, Brixel R, Schüle R, Solano ME, Brune W, Stahl FR.   +8 more
europepmc   +1 more source

Beyond mobility: A prospective study on diet and metabolism in hereditary spastic paraplegia. [PDF]

Metab Brain Dis
Erhardt C, Spatz IT, Herrmann HJ, Kohl Z, Zopf Y, Gassner H, Winkler J, Regensburger M.   +7 more
europepmc   +1 more source

Schule als Schule der Demokratie?

Fokus Lehrerbildung
openaire   +1 more source

An Investigation of Corticospinal Tract Microstructural Integrity in ARSACS Using a Profilometry MRI Analysis: Results From the PROSPAX Study. [PDF]

Eur J Neurol
Scaravilli A, Mari G, Gabusi I, Battocchio M, Bosticardo S, Schiavi S, Bender B, Kessler C, La Piana R, van de Warrenburg BP, Cosottini M, Timmann D, PROSPAX Consortium, Daducci A, Schüle R, Synofzik M, Santorelli FM, Cocozza S.   +17 more
europepmc   +1 more source

Overexpression of KMT9α is associated with poor outcome in cholangiocarcinoma patients. [PDF]

J Cancer Res Clin Oncol
Kinzler MN, Metzger E, Schulz R, Bankov K, Ramos-Triguero A, Schulze F, Gretser S, Abedin N, Wiegering A, Zeuzem S, Walter D, Reis H, Schüle R, Wild PJ.   +13 more
europepmc   +1 more source

Sensitization of Non-M3 Acute Myeloid Leukemia Blasts to All-Trans Retinoic Acid by the LSD1 Inhibitor Tranylcypromine: TRANSATRA Phase I Study. [PDF]

Eur J Haematol
Kruszewski M, Schmoor C, Berg T, Rehman UU, Schittenhelm M, Götze K, Kündgen A, Pabst C, Ma T, Frey A, Stomper J, Pfeifer D, Metzger E, Jung J, Moschallski K, Thomas J, Bug G, Duyster J, Jung M, Schüle R, Wäsch R, Grishina O, Lübbert M.   +22 more
europepmc   +1 more source

A 24-year pharmacovigilance study on sex differences in adverse drug reactions to antidepressant drugs. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Seifert J, Grohmann R, Toto S, Reinhard MA, Bleich S, Erfurth A, Schüle C, Stübner S, Glocker C.   +8 more
europepmc   +1 more source

Spastic Ataxia Composite (SPAXCOM): A Scale to Evaluate the Progression of Subjects with Spasticity and Ataxia. [PDF]

Mov Disord
Di Folco C, Dubec-Fleury C, Traschütz A, Kessler C, Reich S, Gagnon C, Lessard I, Rodrigue X, Cocozza S, Satolli S, Santorelli FM, Durr A, Heinzmann A, van de Warrenburg BP, Willemse IHJ, Başak AN, Vural A, Brais B, Klebe S, Horvath R, PROSPAX Consortium, Schüle R, Synofzik M, Tezenas du Montcel S.   +23 more
europepmc   +1 more source

Correction: Assessing the impact of an evidence- and consensus-based guideline for controlling SARS-CoV-2 transmission in German schools on decision-making processes: a multi-component qualitative analysis. [PDF]

Health Res Policy Syst
Wabnitz K, Rueb M, Rehfuess EA, Strahwald B, Pfadenhauer LM.   +4 more
europepmc   +1 more source